Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong ARURA Pharmaceutical R&D is a pharmaceutical research and development company based in Jinan, China, specializing in the modernization of traditional Tibetan medicines and the development of generic pharmaceuticals. As a subsidiary of Jinhe Tibetan Medicine, the company provides clinical trial materials, including active drugs and placebos, for large-scale multi-center clinical trials in China. Its research focus includes the development of traditional formulations such as the Ruyi Zhenbao pill for neurological recovery and Anerning granules for viral pneumonia. The company is GMP-certified and maintains strong collaborations with academic institutions like Yantai University and major hospitals to advance clinical research in neurosurgery and cardiovascular health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong ARURA Pharmaceutical R&D.